Skip to content

RPRXROYALTY PHARMA PLC- CL A

CUSIP G7709Q104 · common stock

5 tracked investors held ROYALTY PHARMA PLC- CL A (RPRX) at the end of Q3 2026, worth $395M in total. The largest holder was Samantha McLemore, with 6.3% of its portfolio.

Holders · Q3 2026
5
New holders
0
Value held
$395M
Quarter-end price (est.)
$58.36

Investors holding RPRX · Q3 2026

InvestorWeightSharesValueChange
Samantha McLemore
Patient Capital Management, LLC
6.35%3,422,067$199.7MREDUCE-4.9%
Pat Dorsey
Dorsey Asset Management, LLC
8.23%2,415,667$141MREDUCE-1.7%
Torray Funds
Torray Investment Partners LLC
4.35%564,461$32.9MREDUCE-6.2%
Murray Stahl
Horizon Kinetics Asset Management LLC
0.26%353,191$20.6MADD+2.4%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.03%12,500$729.5KHOLD

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026500$395M$58.36
Q2 2026500$393.3M$56.07
Q1 2026510$331.5M$47.97
Q4 2025400$258.5M$38.64
Q2 2022001$0—
Q1 2022100$58.3M$38.96
Q4 2021100$344.6M$39.85
Q3 2021110$475.1M$36.14